ELITE 2021 Strategist Sumant Rajendran of Scilex Pharmaceuticals

Sumant Rajendran

Senior Director, Marketing

Scilex Pharmaceuticals

The Overlooked Opportunity Identifier

Sumant Rajendran describes his role as a marketer as the ability to identify “opportunity pools.” In other words, the areas of opportunity other people have overlooked.

The latest example of that is at Scilex with ZTlido, a topical lidocaine patch used to relieve nerve pain following healing from shingles. Previously, ZTlido’s calling card was the fact that it sticks better than its generic competition. But Sumant saw another angle that everyone (including the KOLs) had overlooked: ZTlido is arguably as efficacious—if not better—than Lyrica (pregabalin) the blockbuster gold standard drug for treating neuropathic pain that has now gone generic. But it goes beyond even that.

ZTlido can be combined with gabapentinoids based on mechanism of action (MOA), leading to explosive efficacy, while allowing clinicians to lower the gabapentin dose, thereby reducing risk of systemic adverse events. Going even further, data also shows that combining these two therapies can dramatically reduce the use of opioids, so you are essentially killing two birds with one stone.

Now Sumant is relaunching the brand a little over two years into its lifecycle—and he is doing it during a pandemic. Without great execution, great vision is just pie in the sky, Sumant believes; so he has rapidly pivoted to executing effectively in the virtual environment. Physicians are able to order samples directly from the website, the sales force is trained in virtual selling of e-modules and armed with the ability to send impactful and personalized emails, and a novel remote speakers bureau that piggybacks off sales lunch-and-learns is being deployed.

This is just the latest in a long line of successes for Sumant, which previously included doubling net sales for Aloxi, a treatment to reduce nausea and vomiting from chemo, to $125 million in two years, despite a flat, genericized market. The secret was identifying the overlooked commercial opportunity in the hospital channel space.

The bottom line: once Sumant identifies the right angle, he is relentless in capitalizing on it, and that typically means good things for the brand.

Ads

You May Also Like

Not Your Father’s Marketing Plan

The Four Ps used to be the core of Marketing 101: Product, Price, Place, ...

ELITE 2021 Entrepreneur Noam Solomon of Immunai

Noam Solomon CEO and Co-Founder Immunai Mapping and Reprogramming the Immune System Noam Solomon ...